.jpg)
.jpg)
.jpeg)
Digital ArchiveThis story is part of our historical records. While preserved for reference, some details and facts may have evolved since its original publication 6 months ago.
Societal CDMO Selected By AmyriAD Pharma to Provide Clinical Trials Services to Support Pivotal Phase 3 Program For Alzheimer’s Disease Treatment, AD101
Activities Planned at Both Georgia and California Facilities, Highlighting Benefits of Societal’s Bi-Coastal Footprint Activities Planned at Both Georgia and California Facilities, Highlighting Benefits of Societal’s Bi-Coastal Footprint
B
Business
NEWS CARD
“Societal CDMO Selected By AmyriAD Pharma to Provide Clinical Trials Services to Support Pivotal Phase 3 Program For Alzheimer’s Disease Treatment, AD101”
Read more onthebizzstories.com
2 Jun 2022
Activities Planned at Both Georgia and California Facilities, Highlighting Benefits of Societal’s Bi-Coastal Footprint
Activities Planned at Both Georgia and California Facilities, Highlighting Benefits of Societal’s Bi-Coastal Footprint
historyThis is an archived post. The information provided may be outdated.
